News Analysis

» business and CRISPR

Most Recent

image: Top Technical Advances in 2017

Top Technical Advances in 2017

By | December 25, 2017

The year’s most impressive achievements include new methods to extend CRISPR editing, patch-clamp neurons hands-free, and analyze the contents of live cells.

1 Comment

image: 2017’s Science News in Review

2017’s Science News in Review

By | December 15, 2017

Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: RNAi’s Future in Drug-Target Screening

RNAi’s Future in Drug-Target Screening

By | April 17, 2017

A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

0 Comments

image: With CRISPR, Modeling Disease in Mini Organs

With CRISPR, Modeling Disease in Mini Organs

By | May 6, 2016

Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.

0 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Credit for CRISPR: A Conversation with George Church

Credit for CRISPR: A Conversation with George Church

By | December 29, 2015

The media frenzy over the gene-editing technique highlights shortcomings in how journalists and award committees portray contributions to scientific discoveries.

9 Comments

image: Year in Review: CRISPR Blossoms

Year in Review: CRISPR Blossoms

By | December 16, 2015

As researchers work to improve the precision gene-editing technology, the community discusses the best way to use it.

0 Comments

image: The Unregulation of Biotech Crops

The Unregulation of Biotech Crops

By | November 25, 2015

Genetic engineering—once a trigger for federal oversight—is now ushering some modified crops around scrutiny.

2 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

7 Comments

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS